not tagged
eli lilly
['bcsm', 'breast']
at #asco22, we re announcing a new adjuvant trial called ember-4, studying our investigational serd for patients with er+, her2- #earlybreastcancer who have an increased risk of recurrence. #breastcancer #bcsm #clinicaltrials 
US healthcare providers’ home for emerging science from Lilly Oncology and Loxo Oncology at Lilly. Please see our community guidelines: https://t.co/1q8vAe63mK